Literature DB >> 24530421

A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.

Jacques Jean-Philippe1, Sean Paz1, Michael L Lu1, Massimo Caputi2.   

Abstract

Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) is one of the most abundant RNA binding proteins. hnRNP A1 is localized prevalently in the nucleus but it can relocate to the cytoplasm in response to specific stimuli shuttling between nuclear and cytoplasmic compartments. The cellular localization of this protein is regulated by a short C-terminus motif (M9) and other less defined sequences. The RNA binding specificity of this protein is dependent on multiple RNA binding domains (RBDs), which regulate its role in RNA processing and expression. hnRNP A1 plays multiple roles in gene expression by regulating the biogenesis and translation of messengers RNAs, the processing of miRNAs, affecting transcription and controlling telomere maintenance. The multiple functions of this protein correlate with diverse roles in genetic disease, cancer and the replication of viral pathogens. Utilizing a tagged hnRNP A1 deletion library we have shown that the three hnRNP A1 RBDs contribute to the prevalent nuclear distribution of the protein. Our data also indicate that a truncated form of the protein, lacking one of the RBDs, the RGG-box, can regulate splicing of a splicing reporter minigene and down-regulate replication of the HIV-1 virus with efficiency comparable to the wild-type protein. This functional hnRNP A1 deletion mutant is similar to a predicted hnRNP A1 isoform, which had not been previously experimentally characterized.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; HIV-1; RGG-box; RRM; hnRNP A1

Mesh:

Substances:

Year:  2014        PMID: 24530421      PMCID: PMC3981607          DOI: 10.1016/j.bbagrm.2014.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  42 in total

1.  Control of nuclear export of hnRNP A1.

Authors:  M Lichtenstein; W Guo; A M Tartakoff
Journal:  Traffic       Date:  2001-04       Impact factor: 6.215

Review 2.  A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter.

Authors:  L A Pereira; K Bentley; A Peeters; M J Churchill; N J Deacon
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

3.  The hnRNP A1 protein regulates HIV-1 tat splicing via a novel intron silencer element.

Authors:  T O Tange; C K Damgaard; S Guth; J Valcárcel; J Kjems
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

4.  hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.

Authors:  Christian Kroun Damgaard; Thomas Ostergaard Tange; Jørgen Kjems
Journal:  RNA       Date:  2002-11       Impact factor: 4.942

5.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.

Authors:  J Zhu; A Mayeda; A R Krainer
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

Review 7.  Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.

Authors:  Uriya Bekenstein; Hermona Soreq
Journal:  Mol Cell Neurosci       Date:  2012-12-14       Impact factor: 4.314

8.  Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer.

Authors:  Irene Pino; Rubén Pío; Gemma Toledo; Natalia Zabalegui; Silvestre Vicent; Natalia Rey; María D Lozano; Wenceslao Torre; Jesús García-Foncillas; Luis M Montuenga
Journal:  Lung Cancer       Date:  2003-08       Impact factor: 5.705

9.  SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.

Authors:  Alan M Zahler; Christian K Damgaard; Jorgen Kjems; Massimo Caputi
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

10.  Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR.

Authors:  Ana Rebane; Alar Aab; Joan A Steitz
Journal:  RNA       Date:  2004-04       Impact factor: 4.942

View more
  7 in total

1.  Scaffold attachment factor B suppresses HIV-1 infection of CD4+ T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat.

Authors:  Li Ma; Li Sun; Xia Jin; Si-Dong Xiong; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

Review 2.  Stress proteins: the biological functions in virus infection, present and challenges for target-based antiviral drug development.

Authors:  Qianya Wan; Dan Song; Huangcan Li; Ming-Liang He
Journal:  Signal Transduct Target Ther       Date:  2020-07-13

Review 3.  RNA-binding proteins with prion-like domains in health and disease.

Authors:  Alice Ford Harrison; James Shorter
Journal:  Biochem J       Date:  2017-04-07       Impact factor: 3.857

Review 4.  Let It Go: HIV-1 cis-Acting Repressive Sequences.

Authors:  Philipp Niklas Ostermann; Anastasia Ritchie; Johannes Ptok; Heiner Schaal
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

5.  HIV-1 transcription is regulated by splicing factor SRSF1.

Authors:  Sean Paz; Adrian R Krainer; Massimo Caputi
Journal:  Nucleic Acids Res       Date:  2014-12-16       Impact factor: 16.971

Review 6.  Contribution of the Degeneration of the Neuro-Axonal Unit to the Pathogenesis of Multiple Sclerosis.

Authors:  Hannah E Salapa; Sangmin Lee; Yoojin Shin; Michael C Levin
Journal:  Brain Sci       Date:  2017-06-18

Review 7.  Can the HIV-1 splicing machinery be targeted for drug discovery?

Authors:  Zodwa Dlamini; Rodney Hull
Journal:  HIV AIDS (Auckl)       Date:  2017-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.